Enhancement of alloimmunization: a potential hazard of GM-CSF treatment in patients with severe aplastic anemia?
Kuentz
M
M
Bierling
P
P
Norolle
F
F
Cordonnier
C
C
Rochant
H
H
Vernant
J P
JP
D000328:Adult; D000741:Anemia, Aplastic / Q000628:therapy*; D001787:Blood Group Incompatibility / Q000209:etiology*; D003115:Colony-Stimulating Factors / Q000009:adverse effects*; D016178:Granulocyte-Macrophage Colony-Stimulating Factor; D006133:Growth Substances / Q000009:adverse effects*; D006801:Humans; D008297:Male; D065227:Transfusion Reaction
D003115:Colony-Stimulating Factors; D006133:Growth Substances; D016178:Granulocyte-Macrophage Colony-Stimulating Factor